4 completed, 1 terminated. 2 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow firibastat: new trials by email Literature Review of firibastat trials Research Report on firibastat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) Firibastat (QGC001) Period 1 - Hypertension (HTN) | Phase 3 | Terminated | Quantum Genomics SA | 419 | 2021-08-05 | 2023-01-17 |
| Firibastat in Treatment-resistant Hypertension Firibastat, Placebo - Hypertension | Phase 3 | Completed | Quantum Genomics SA | 515 | 2020-06-25 | 2022-10-20 |
| Pharmacokinetics in End Stage Renal Disease Patients firibastat - Healthy Volunteers, Renal Failure | Phase 1 | Completed | Quantum Genomics SA | 28 | 2019-09-17 | 2021-03-10 |
| Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction Ramipril, Firibastat - Myocardial Infarction | Phase 2 | Completed | Quantum Genomics SA | 295 | 2019-06-04 | 2023-02-27 |
| Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations Firibastat - Healthy Males | Phase 1 | Completed | Quantum Genomics SA | 12 | 2019-02-15 | 2019-06-18 |
Hypertension (2) · Myocardial Infarction (1) · Renal Insufficiency (1)
France (3) · Germany (2) · Poland (2) · Spain (2) · United Kingdom (2) · United States (2) · Canada (1) · Czechia (1) · Hungary (1) · Slovakia (1)
George Bakris, MD (1) · Gilles Montalescot, MD, PhD (1)
2018 (1), 2019 (1)